Background: Exposure to stress levels of glucocorticoids produces physiological responses that are characteristic of type 2 diabetes, such as peripheral insulin resistance and impairment in insulin-stimulated trafficking of glucose transporter 4 (GLUT4) in muscle and fat. In the central nervous system, stress produces neuroanatomical and neurochemical changes in the hippocampus that are associated with cognitive impairments. Methods: In view of these observations, the current studies examined the effects of short-term (1 week) exposure of stress levels of glucocorticoids upon insulin receptor (IR) expression and signaling, including GLUT4 translocation, in the rat hippocampus. Results: One week of corticosterone (CORT) treatment produced insulin resistance in response to peripheral glucose challenge. In the hippocampus, IR expression was unchanged in CORT-treated rats as compared with vehicle-treated rats. However, insulin-stimulated phosphorylation of the IR, total Akt levels and total GLUT4 levels were reduced in CORT-treated rats when compared to controls. In addition, insulin-stimulated translocation of hippocampal GLUT4 to the plasma membrane was completely abolished in CORT-treated rats. Conclusions: These results demonstrate that in addition to eliciting peripheral insulin resistance, short-term CORT administration impairs insulin signaling in the rat hippocampus, effects that may contribute to the deleterious consequences of hypercortisolemic/hyperglycemic states observed in type 2 diabetes.

Keywords:
Glucocorticoid, Glucose, Hyperglycemia, Insulin resistance, Diabetes, Akt levels
1.
Pardridge WM: Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev 1983;63:1481–1535.
2.
Lund-Anderen H: Transport of glucose from blood to brain. Physiol Rev 1979;59:305–310.
3.
Messier C, Gagnon M: Glucose regulation and cognitive functions: relation to Alzheimer’s disease and diabetes. Behav Brain Res 1996;75:1–11.
4.
Simpson IA, Chunda KR, Davies-Hill T, Honer WG, Davies P: Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer’s disease. Ann Neurol 1994;35:546–551.
5.
Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE: Diminished glucose transport and phosphorylation in Alzheimer’s disease determined by dynamic FDG-PET. J Nucl Med 1996;37:201–208.
6.
Craft S, Dagogo-Jack SE, Wiethop BV, Murphy C, Nevins RT, Fleischman S, Rice V, Newcomer JW, Cryer PE: Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav Neurosci 1993;107:926–940.
7.
Craft S, Newcomer JW, Kanne S, Dagogo-Jack SE, Cryer PE, Sheline Y, Luby J, Dagogo-Jack A, Alderson AL: Memory improvement following induced hyperinsulinemia in Alzheimer’s disease. Neurobiol Aging 1996;17:123–130.
8.
Richardson JT: Cognitive function in diabetes mellitus. Neurosci Biobehav Rev 1990;14:385–388.
9.
Couch RM: Dissociation of cortisol and adrenal androgen secretion in poorly controlled insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh) 1992;127:115–117.
10.
de Leon MJ, McRae T, Rusinek H, Convit A, De Santi S, Tarshish C, Golomb J, Volkow N, Daisley K, Orentreich N, McEwen BS: Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer’s disease. J Clin Endocrinol Metab 1997;82:3251–3259.
11.
Horner HC, Packan DR, Sapolsky RM: Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 1990;52:57–64.
12.
Kadekaro M, Ito M, Gross PM: Local cerebral glucose utilization is increased in acutely adrenalectomized rats. Neuroendocrinology 1988;47:329–334.
13.
Virgin CE Jr, Ha TP, Packan DR, Tombaugh GC, Yang SH, Horner HC, Sapolsky RM: Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J Neurochem 1991;57:1422–1428.
14.
Luine V, Villegas M, Martinez C, McEwen BS: Repeated stress causes reversible impairments of spatial memory performance. Brain Res 1994;639:167–170.
15.
Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME: Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 1994;14:2047–2053.
16.
Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL: Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 1999;56:527– 533.
17.
Lupien SJ, de Leon MJ, De Santi S, Convit A, Tarshish C, Nair NP, McEwen BS, Hauger RL, Meaney MJ: Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998;1:69–73.
18.
de Quervain DJ, Roozendaal B, McGaugh JL: Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 1998;394:787–790.
19.
Amatruda JM, Livingston JN, Lockwood DH: Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess, and chronic renal failure. Diabetes Metab Rev 1985;1:293–317.
20.
McMahon M, Gerich J, Rizza R: Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 1988;4:17–30.
21.
Charron MJ, Brosius FC III, Alper SL, Lodish HF: A glucose transport protein expressed predominately in insulin-responsive tissues. Proc Natl Acad Sci USA 1989;86:2535–2539.
22.
Birnbaum MJ: Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell 1989;57:305–315.
23.
James DE, Strube M, Mueckler M: Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 1989;338:83–87.
24.
Fukumoto H, Kayano T, Buse JB, Edwards Y, Pilch PF, Bell GI, Seino S: Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J Biol Chem 1989;264:7776–7779.
25.
Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, Newsholme EA: Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 1997;321(Pt 3):707–712.
26.
Coderre L, Vallega GA, Pilch PF, Chipkin SR: In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. Am J Physiol 1996;271(4 Pt 1):E643–E648.
27.
Weinstein SP, Wilson CM, Pritsker A, Cushman SW: Dexamethasone inhibits insulin-stimulated recruitment of GLUT4 to the cell surface in rat skeletal muscle. Metabolism 1998;47:3–6.
28.
Garvey WT, Huecksteadt TP, Lima FB, Birnbaum MJ: Expression of a glucose transporter gene cloned from brain in cellular models of insulin resistance: dexamethasone decreases transporter mRNA in primary cultured adipocytes. Mol Endocrinol 1989;3:1132–1141.
29.
Kobayashi M, Nikami H, Morimatsu M, Saito M: Expression and localization of insulin-regulatable glucose transporter (GLUT4) in rat brain. Neurosci Lett 1996;213:103–106.
30.
Messari SE, LeLoup C, Quignon M, Brisorgueil MJ, Penicaud L, Arluison M: Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system. J Comp Neurol 1998;399:492–512.
31.
Vannucci SJ, Koehler-Stec EM, Li K, Reynolds TH, Clark R, Simpson IA: GLUT4 glucose transporter expression in rodent brain: effects of diabetes. Brain Res 1998;797:1–11.
32.
McEwen BS, Reagan LP: Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 2004;490:13–24.
33.
Kar S, Chabot JG, Quirion R: Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain. J Comp Neurol 1993;333:375–397.
34.
Marks JL, Porte D Jr, Stahl WL, Baskin DG: Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 1991;127:3234–3236.
35.
Winocur G, Greenwood CE, Piroli GG, Grillo CA, Reznikov LR, Reagan LP, McEwen BS: Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci 2005;119:1389–1395.
36.
Reagan LP: Neuronal insulin signal transduction mechanisms in diabetes phenotypes. Neurobiol Aging 2005;26(Suppl 1):56–59.
37.
Magarinos AM, Orchinik M, McEwen BS: Morphological changes in the hippocampal CA3 region induced by non-invasive glucocorticoid administration: a paradox. Brain Res 1998;809:314–318.
38.
Reagan LP, Magariños AM, Yee DK, Szweda LI, Van Bueren A, McCall AL, McEwen BS: Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res 2000;862:292–300.
39.
Zhao W, Chen H, Moore E, Meiri N, Quon MJ, Alkon DL: Brain insulin receptors and spatial memory. J Biol Chem 1999;274:34893–34902.
40.
Zhao WQ, Alkon DL: Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 2001;177:125–134.
41.
Piroli GG, Grillo CA, Hoskin EK, Znamensky V, Katz EB, Milner TA, McEwen BS, Charron MJ, Reagan LP: Peripheral glucose administration stimulates the translocation of GLUT8 glucose transporter to the endoplasmic reticulum in the rat hippocampus. J Comp Neurol 2002;452:103–114.
42.
Galea LA, McEwen BS, Tanapat P, Deak T, Spencer RL, Dhabhar FS: Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress. Neuroscience 1997;81:689–697.
43.
Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, Bue-Valleskey J, Stephens TW: Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996;271:5301–5304.
44.
De Vos P, Saladin R, Auwerx J, Staels B: Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995;270:15958–15961.
45.
Murakami T, Iida M, Shima K: Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Commun 1995;214:1260–1267.
46.
Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R: Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002;290:1084–1089.
47.
Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R: Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003;301:1045–1050.
48.
Fasshauer M, Paschke R: Regulation of adipocytokines and insulin resistance. Diabetologia 2003;46:1594–1603.
49.
Buren J, Liu HX, Jensen J, Eriksson JW: Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur J Endocrinol 2002;146:419–429.
50.
Garvey WT, Huecksteadt TP, Monzon R, Marshall S: Dexamethasone regulates the glucose transport system in primary cultured adipocytes: different mechanisms of insulin resistance after acute and chronic exposure. Endocrinology 1989;124:2063–2073.
51.
Haber RS, Weinstein SP: Role of glucose transporters in glucocorticoid-induced insulin resistance: GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone. Diabetes 1992;41:728–735.
52.
Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ: Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 1993;91:2020–2030.
53.
Klip A, Ramlal T, Bilan PJ, Cartee GD, Gulve EA, Holloszy JO: Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle. Biochem Biophys Res Commun 1990;172:728–736.
54.
Marette A, Richardson JM, Ramlal T, Balon TW, Vranic M, Pessin JE, Klip A: Abundance, localization, and insulin-induced translocation of glucose transporters in red and white muscle. Am J Physiol 1992;263 (2 Pt 1):C443–C452.
55.
Banks WA, Kastin AJ: Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 1998;19:883–889.
56.
Ishiki M, Klip A: Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 2005;146:5071–5078.
57.
Zeller K, Duelli R, Vogel J, Schrock H, Kuschinsky W: Autoradiographic analysis of the regional distribution of Glut3 glucose transporters in the rat brain. Brain Res 1995;698:175–179.
58.
Duelli R, Maurer MH, Staudt R, Heiland S, Duembgen L, Kuschinsky W: Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain. Brain Res 2000;858:338–347.
59.
Pavlides C, Watanabe Y, McEwen BS: Effects of glucocorticoids on hippocampal long-term potentiation. Hippocampus 1993;3:183–192.
60.
Abraham I, Juhasz G, Kekesi KA, Kovacs KJ: Corticosterone peak is responsible for stress-induced elevation of glutamate in the hippocampus. Stress 1998;2:171–181.
61.
Chao HM, Sakai RR, Ma LY, McEwen BS: Adrenal steroid regulation of neurotrophic factor expression in the rat hippocampus. Endocrinology 1998;139:3112–3118.
62.
Lowy MT, Gault L, Yamamoto BK: Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J Neurochem 1993;61:1957–1960.
63.
Moghaddam B, Bolinao ML, Stein-Behrens B, Sapolsky R: Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Res 1994;655:251–254.
64.
Woolley CS, Gould E, McEwen BS: Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 1990;531:225–231.
65.
Grillo CA, Piroli GG, Wood GE, Reagan LP, McEwen BS: Radioimmunocytochemical analysis of synaptic proteins provides a reliable measure of morphological changes in the rat hippocampus. Soc Neurosci Abstr 2003:33.
66.
Grillo CA, Piroli GG, Wood GE, Reznikov LR, McEwen BS, Reagan LP: Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 2005;136:477–486.
67.
Orchinik M, Weiland NG, McEwen BS: Chronic exposure to stress levels of corticosterone alters GABAA receptor subunit mRNA levels in rat hippocampus. Brain Res Mol Brain Res 1995;34:29–37.
68.
Weiland NG, Orchinik M, Tanapat P: Chronic corticosterone treatment induces parallel changes in N-methyl-D-aspartate receptor subunit messenger RNA levels and antagonist binding sites in the hippocampus. Neuroscience 1997;78:653–662.
69.
Barr AM, Brotto LA, Phillips AG: Chronic corticosterone enhances the rewarding effect of hypothalamic self-stimulation in rats. Brain Res 2000;875:196–201.
70.
Brotto LA, Gorzalka BB, Barr AM: Paradoxical effects of chronic corticosterone on forced swim behaviours in aged male and female rats. Eur J Pharmacol 2001;424:203–209.
71.
Venkatesan N, Lim J, Bouch C, Marciano D, Davidson MB: Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. Metabolism 1996;45:92–100.
72.
Weinstein SP, Paquin T, Pritsker A, Haber RS: Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes 1995;44:441–445.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.